7
|
Tian Y, Zhang Z, Jing J, Dong K, Mo D, Wang Y. Anatomic Variation of the Lateral Sinus in Patients With Idiopathic Intracranial Hypertension: Delineation With Black-Blood Contrast-Enhanced MRI. Front Neurol 2021; 12:715857. [PMID: 34899556 PMCID: PMC8656160 DOI: 10.3389/fneur.2021.715857] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/27/2021] [Accepted: 10/27/2021] [Indexed: 11/15/2022] Open
Abstract
Objectives: The purpose of this study was to describe the peculiar anatomic variations in the lateral sinus and analyze the patterns of cerebrospinal fluid (CSF) drainage by using high-resolution (HR) black-blood (BB) contrast-enhanced magnetic resonance imaging (MRI) in patients with idiopathic intracranial hypertension (IIH). Methods: Total 33 IIH patients who were found cerebral venous sinus stenosis (CVSS) by MR venography (MRV) were enrolled in this study. HR-BB contrast-enhanced MRI was used to assess the features of anatomical variations in transverse sinus and sigmoid sinus. The development of bilateral sinuses was firstly evaluated, including unilateral hypoplasia with contralateral dominance or bilateral balanced development. Then, four kinds of anatomical variations were eventually recorded, including circumscribed stenosis, arachnoid granulation (AG), fibrous septum (FS), and brain herniation (BH) into dural venous sinus (DVS). Results: Bilateral venous drainage dysfunction was found in 30(90.9%) patients, whereas only 3(9.1%) patients presented unilateral venous drainage dysfunction. There was no difference in clinical symptoms between the two groups. The most common case is hypoplasia in unilateral sinus combined with anatomic variation in the contralateral dominant transverse sinus such as AG and BH into DVS. Total of 52 anatomic variations were finally found in bilateral sinuses in 33 enrolled patients, including 19(36.5%)AGs, 12(23.1%)FS, 7(13.5%) BH into DVS and 14(26.9%) circumscribed stenoses. Moreover, 41(62.1%) lateral sinuses showed enhancement in T1-weight-enhanced MRI. Conclusions: Patients with CVSS almost had CSF outflow disorders, whatever bilateral equalization or unilateral hypoplasia with contralateral dominance. Four types of main anatomic variations, including circumscribed stenosis, AG, FS, and BH into DVS, caused venous reflux obstruction by elevating the intracranial press (ICP).
Collapse
Affiliation(s)
- Yu Tian
- Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.,Chinese Institute for Brain Research, Beijing, China.,China National Clinical Research Center for Neurological Diseases, Beijing, China.,Advanced Innovation Center for Human Brain Protection, Capital Medical University, Beijing, China.,Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing, China
| | - Zhe Zhang
- Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.,Chinese Institute for Brain Research, Beijing, China.,China National Clinical Research Center for Neurological Diseases, Beijing, China.,Advanced Innovation Center for Human Brain Protection, Capital Medical University, Beijing, China.,Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing, China
| | - Jing Jing
- Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.,Chinese Institute for Brain Research, Beijing, China.,China National Clinical Research Center for Neurological Diseases, Beijing, China.,Advanced Innovation Center for Human Brain Protection, Capital Medical University, Beijing, China.,Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing, China
| | - Kehui Dong
- Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.,Chinese Institute for Brain Research, Beijing, China.,China National Clinical Research Center for Neurological Diseases, Beijing, China.,Advanced Innovation Center for Human Brain Protection, Capital Medical University, Beijing, China.,Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing, China
| | - Dapeng Mo
- Chinese Institute for Brain Research, Beijing, China.,China National Clinical Research Center for Neurological Diseases, Beijing, China.,Advanced Innovation Center for Human Brain Protection, Capital Medical University, Beijing, China.,Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing, China.,Department of Interventional Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
| | - Yilong Wang
- Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.,Chinese Institute for Brain Research, Beijing, China.,China National Clinical Research Center for Neurological Diseases, Beijing, China.,Advanced Innovation Center for Human Brain Protection, Capital Medical University, Beijing, China.,Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing, China
| |
Collapse
|
10
|
Song SY, Dornbos D, Lan D, Jiao BL, Wan SL, Guo YB, Ding YC, Yang Q, Ji XM, Meng R. High-Resolution Magnetic Resonance Black Blood Thrombus Imaging and Serum D-Dimer in the Confirmation of Acute Cortical Vein Thrombosis. Front Neurol 2021; 12:680040. [PMID: 34234736 PMCID: PMC8255931 DOI: 10.3389/fneur.2021.680040] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/16/2021] [Accepted: 05/12/2021] [Indexed: 11/13/2022] Open
Abstract
Cerebral cortical vein thrombosis (CCVT) is often misdiagnosed because of its non-specific diagnostic symptoms. Here, we analyzed a cohort of patients with CCVT in hopes of improving understandings and treatments of the disease. A total of 23 patients with CCVT (confirmed with high-resolution imaging), who had been diagnosed between 2017 and 2019, were enrolled in this cohort study. Baseline demographics, clinical manifestations, laboratory data, radiological findings, treatment, and outcomes were collected and analyzed. Fourteen females and nine males were enrolled (mean age: 32.7 ± 11.9 years), presenting in the acute (within 7 days, n = 9), subacute (8–30 days, n = 7), and chronic (over 1 month, n = 7) stages. Headaches (65.2%) and seizures (39.1%) were the most common symptoms. Abnormally elevated plasma D-dimers were observed in the majority of acute stage patients (87.5%). The diagnostic accuracy of contrast-enhanced magnetic resonance venography (CE-MRV) and high-resolution magnetic resonance black-blood thrombus imaging (HR-MRBTI) in detecting CCVT were 57.1 and 100.0%, respectively. All patients had good functional outcomes after 6-month of standard anticoagulation (mRS 0–1) treatment. However, four CCVT patients that had cases involving multiple veins showed symptom relief after batroxobin therapy (p = 0.030). HR-MRBTI may be a fast and accurate tool for non-invasive CCVT diagnosis. HR-MRBTI combined with D-dimer can also precisely identify the pathological stage of CCVT. Batroxobin may safely accelerate cortical venous recanalization in combination with anticoagulation. Follow-up studies with larger sample sizes are suggested to evaluate the safety and efficacy of batroxobin for treating CCVT.
Collapse
Affiliation(s)
- Si-Ying Song
- Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China.,Advanced Center of Stroke, Beijing Institute for Brain Disorders, Beijing, China.,Department of China-America Institute of Neuroscience, Xuanwu Hospital, Capital Medical University, Beijing, China
| | - David Dornbos
- Department of Neurological Surgery, Semmes-Murphey Clinic and University of Tennessee Health Science Center, Memphis, TN, United States
| | - Duo Lan
- Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China.,Advanced Center of Stroke, Beijing Institute for Brain Disorders, Beijing, China.,Department of China-America Institute of Neuroscience, Xuanwu Hospital, Capital Medical University, Beijing, China
| | - Bao-Lian Jiao
- Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China.,Advanced Center of Stroke, Beijing Institute for Brain Disorders, Beijing, China.,Department of China-America Institute of Neuroscience, Xuanwu Hospital, Capital Medical University, Beijing, China
| | - Shu-Ling Wan
- Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China.,Advanced Center of Stroke, Beijing Institute for Brain Disorders, Beijing, China.,Department of China-America Institute of Neuroscience, Xuanwu Hospital, Capital Medical University, Beijing, China
| | - Yi-Bing Guo
- Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China.,Advanced Center of Stroke, Beijing Institute for Brain Disorders, Beijing, China.,Department of China-America Institute of Neuroscience, Xuanwu Hospital, Capital Medical University, Beijing, China
| | - Yu-Chuan Ding
- Advanced Center of Stroke, Beijing Institute for Brain Disorders, Beijing, China.,Department of China-America Institute of Neuroscience, Xuanwu Hospital, Capital Medical University, Beijing, China.,Department of Neurosurgery, Wayne State University School of Medicine, Detroit, MI, United States
| | - Qi Yang
- Advanced Center of Stroke, Beijing Institute for Brain Disorders, Beijing, China.,Department of Radiology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China
| | - Xun-Ming Ji
- Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China.,Advanced Center of Stroke, Beijing Institute for Brain Disorders, Beijing, China.,Department of China-America Institute of Neuroscience, Xuanwu Hospital, Capital Medical University, Beijing, China
| | - Ran Meng
- Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China.,Advanced Center of Stroke, Beijing Institute for Brain Disorders, Beijing, China.,Department of China-America Institute of Neuroscience, Xuanwu Hospital, Capital Medical University, Beijing, China
| |
Collapse
|
12
|
Ding Y, Leng X, Nie X, Pan Y, Li J, Liu D, Yan H, Pu Y, Wei Y, Cai Y, Lu Q, Zhang Z, Duan W, Gu W, Hou X, Yang Z, Wen M, Ma N, Miao Z, Wang Y, Liu L. Intraluminal Thrombus and Outcomes of Patients With Acute Large Vessel Occlusive Stroke Undergoing Endovascular Treatment. Stroke 2021; 52:1473-1477. [PMID: 33657858 DOI: 10.1161/strokeaha.120.032876] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
BACKGROUND AND PURPOSE Intraluminal thrombus (ILT) is an emerging imaging marker in acute ischemic stroke. We aimed to investigate the association of ILT with outcomes of acute large vessel occlusion (LVO) patients receiving endovascular treatment. METHODS Acute LVO stroke patients who underwent endovascular treatment within 24 hours, in a prospective, nationwide registry were enrolled. Pretreatment digital subtraction angiography was reviewed for the presence of ILT. The primary outcome was 90-day functional dependence (modified Rankin Scale scores, 3-6). Secondary outcomes included 24-hour LVO, 90-day death, and symptomatic intracranial hemorrhage. RESULTS Among 711 patients enrolled, 75 (10.5%) with ILT were less likely to have 90-day functional dependence compared with those without ILT (adjusted odds ratio, 0.53 [95% CI, 0.31-0.90]; P=0.021). The same trend was found among those with successful reperfusion (modified Thrombolysis in Cerebral Infarction 2b-3; P=0.008) but not in those without successful reperfusion (P=0.107). Presence of ILT was also independently associated with a lower rate of 24-hour LVO (adjusted odds ratio 0.34 [95% CI, 0.13-0.89]; P=0.028). However, those with or without ILT had similar risks of symptomatic intracranial hemorrhage and 90-day death. CONCLUSIONS Among acute LVO patients receiving endovascular treatment, pretreatment ILT-positive patients may have a better 90-day functional outcome (versus ILT-negative) but similar risk of death and symptomatic intracranial hemorrhage. The possibly favorable effect of ILT patients remained in those with successful reperfusion. Registration: URL: http://www.chictr.org.cn; Unique identifier: ChiCTR1900022154.
Collapse
Affiliation(s)
- Yarong Ding
- Department of Neurology (Y.D., X.N., Y.P., J.L., D.L., Y.P., Y. Wei, Y.C., Q.L., Z.Z., W.D., Z.Y., M.W., N.M., Z.M., Y. Wang, L.L.).,China National Clinical Research Center for Neurological Diseases, Beijing (Y.D., X.N., Y.P., J.L., D.L., H.Y., Y.P., Y. Wei, Y.C., Q.L., Z.Z., W.D., Z.Y., M.W., N.M., Z.M., Y. Wang, L.L.)
| | - Xinyi Leng
- Department of Neurology (Y.D., X.N., Y.P., J.L., D.L., Y.P., Y. Wei, Y.C., Q.L., Z.Z., W.D., Z.Y., M.W., N.M., Z.M., Y. Wang, L.L.).,China National Clinical Research Center for Neurological Diseases, Beijing (Y.D., X.N., Y.P., J.L., D.L., H.Y., Y.P., Y. Wei, Y.C., Q.L., Z.Z., W.D., Z.Y., M.W., N.M., Z.M., Y. Wang, L.L.)
| | - Ximing Nie
- China National Clinical Research Center for Neurological Diseases, Beijing (Y.D., X.N., Y.P., J.L., D.L., H.Y., Y.P., Y. Wei, Y.C., Q.L., Z.Z., W.D., Z.Y., M.W., N.M., Z.M., Y. Wang, L.L.)
| | - Yuesong Pan
- Department of Neurology (Y.D., X.N., Y.P., J.L., D.L., Y.P., Y. Wei, Y.C., Q.L., Z.Z., W.D., Z.Y., M.W., N.M., Z.M., Y. Wang, L.L.).,China National Clinical Research Center for Neurological Diseases, Beijing (Y.D., X.N., Y.P., J.L., D.L., H.Y., Y.P., Y. Wei, Y.C., Q.L., Z.Z., W.D., Z.Y., M.W., N.M., Z.M., Y. Wang, L.L.)
| | - JieJie Li
- Department of Neurology (Y.D., X.N., Y.P., J.L., D.L., Y.P., Y. Wei, Y.C., Q.L., Z.Z., W.D., Z.Y., M.W., N.M., Z.M., Y. Wang, L.L.).,China National Clinical Research Center for Neurological Diseases, Beijing (Y.D., X.N., Y.P., J.L., D.L., H.Y., Y.P., Y. Wei, Y.C., Q.L., Z.Z., W.D., Z.Y., M.W., N.M., Z.M., Y. Wang, L.L.)
| | - Dacheng Liu
- Department of Neurology (Y.D., X.N., Y.P., J.L., D.L., Y.P., Y. Wei, Y.C., Q.L., Z.Z., W.D., Z.Y., M.W., N.M., Z.M., Y. Wang, L.L.).,China National Clinical Research Center for Neurological Diseases, Beijing (Y.D., X.N., Y.P., J.L., D.L., H.Y., Y.P., Y. Wei, Y.C., Q.L., Z.Z., W.D., Z.Y., M.W., N.M., Z.M., Y. Wang, L.L.)
| | - Hongyi Yan
- China National Clinical Research Center for Neurological Diseases, Beijing (Y.D., X.N., Y.P., J.L., D.L., H.Y., Y.P., Y. Wei, Y.C., Q.L., Z.Z., W.D., Z.Y., M.W., N.M., Z.M., Y. Wang, L.L.)
| | - Yuehua Pu
- Department of Neurology (Y.D., X.N., Y.P., J.L., D.L., Y.P., Y. Wei, Y.C., Q.L., Z.Z., W.D., Z.Y., M.W., N.M., Z.M., Y. Wang, L.L.).,China National Clinical Research Center for Neurological Diseases, Beijing (Y.D., X.N., Y.P., J.L., D.L., H.Y., Y.P., Y. Wei, Y.C., Q.L., Z.Z., W.D., Z.Y., M.W., N.M., Z.M., Y. Wang, L.L.)
| | - Yufei Wei
- Department of Neurology (Y.D., X.N., Y.P., J.L., D.L., Y.P., Y. Wei, Y.C., Q.L., Z.Z., W.D., Z.Y., M.W., N.M., Z.M., Y. Wang, L.L.).,China National Clinical Research Center for Neurological Diseases, Beijing (Y.D., X.N., Y.P., J.L., D.L., H.Y., Y.P., Y. Wei, Y.C., Q.L., Z.Z., W.D., Z.Y., M.W., N.M., Z.M., Y. Wang, L.L.)
| | - Yuan Cai
- Department of Neurology (Y.D., X.N., Y.P., J.L., D.L., Y.P., Y. Wei, Y.C., Q.L., Z.Z., W.D., Z.Y., M.W., N.M., Z.M., Y. Wang, L.L.).,China National Clinical Research Center for Neurological Diseases, Beijing (Y.D., X.N., Y.P., J.L., D.L., H.Y., Y.P., Y. Wei, Y.C., Q.L., Z.Z., W.D., Z.Y., M.W., N.M., Z.M., Y. Wang, L.L.)
| | - Qixuan Lu
- Department of Neurology (Y.D., X.N., Y.P., J.L., D.L., Y.P., Y. Wei, Y.C., Q.L., Z.Z., W.D., Z.Y., M.W., N.M., Z.M., Y. Wang, L.L.).,China National Clinical Research Center for Neurological Diseases, Beijing (Y.D., X.N., Y.P., J.L., D.L., H.Y., Y.P., Y. Wei, Y.C., Q.L., Z.Z., W.D., Z.Y., M.W., N.M., Z.M., Y. Wang, L.L.)
| | - Zhe Zhang
- Department of Neurology (Y.D., X.N., Y.P., J.L., D.L., Y.P., Y. Wei, Y.C., Q.L., Z.Z., W.D., Z.Y., M.W., N.M., Z.M., Y. Wang, L.L.).,China National Clinical Research Center for Neurological Diseases, Beijing (Y.D., X.N., Y.P., J.L., D.L., H.Y., Y.P., Y. Wei, Y.C., Q.L., Z.Z., W.D., Z.Y., M.W., N.M., Z.M., Y. Wang, L.L.)
| | - Wanying Duan
- Department of Neurology (Y.D., X.N., Y.P., J.L., D.L., Y.P., Y. Wei, Y.C., Q.L., Z.Z., W.D., Z.Y., M.W., N.M., Z.M., Y. Wang, L.L.).,China National Clinical Research Center for Neurological Diseases, Beijing (Y.D., X.N., Y.P., J.L., D.L., H.Y., Y.P., Y. Wei, Y.C., Q.L., Z.Z., W.D., Z.Y., M.W., N.M., Z.M., Y. Wang, L.L.)
| | - Weibin Gu
- Department of Radiology, Beijing Tiantan Hospital, Capital Medical University, China (W.G., X.H.)
| | - Xinyi Hou
- Department of Radiology, Beijing Tiantan Hospital, Capital Medical University, China (W.G., X.H.)
| | - Zhonghua Yang
- Department of Neurology (Y.D., X.N., Y.P., J.L., D.L., Y.P., Y. Wei, Y.C., Q.L., Z.Z., W.D., Z.Y., M.W., N.M., Z.M., Y. Wang, L.L.).,China National Clinical Research Center for Neurological Diseases, Beijing (Y.D., X.N., Y.P., J.L., D.L., H.Y., Y.P., Y. Wei, Y.C., Q.L., Z.Z., W.D., Z.Y., M.W., N.M., Z.M., Y. Wang, L.L.)
| | - Miao Wen
- Department of Neurology (Y.D., X.N., Y.P., J.L., D.L., Y.P., Y. Wei, Y.C., Q.L., Z.Z., W.D., Z.Y., M.W., N.M., Z.M., Y. Wang, L.L.).,China National Clinical Research Center for Neurological Diseases, Beijing (Y.D., X.N., Y.P., J.L., D.L., H.Y., Y.P., Y. Wei, Y.C., Q.L., Z.Z., W.D., Z.Y., M.W., N.M., Z.M., Y. Wang, L.L.)
| | - Ning Ma
- Department of Neurology (Y.D., X.N., Y.P., J.L., D.L., Y.P., Y. Wei, Y.C., Q.L., Z.Z., W.D., Z.Y., M.W., N.M., Z.M., Y. Wang, L.L.).,China National Clinical Research Center for Neurological Diseases, Beijing (Y.D., X.N., Y.P., J.L., D.L., H.Y., Y.P., Y. Wei, Y.C., Q.L., Z.Z., W.D., Z.Y., M.W., N.M., Z.M., Y. Wang, L.L.)
| | - Zhongrong Miao
- Department of Neurology (Y.D., X.N., Y.P., J.L., D.L., Y.P., Y. Wei, Y.C., Q.L., Z.Z., W.D., Z.Y., M.W., N.M., Z.M., Y. Wang, L.L.).,China National Clinical Research Center for Neurological Diseases, Beijing (Y.D., X.N., Y.P., J.L., D.L., H.Y., Y.P., Y. Wei, Y.C., Q.L., Z.Z., W.D., Z.Y., M.W., N.M., Z.M., Y. Wang, L.L.)
| | - Yongjun Wang
- Department of Neurology (Y.D., X.N., Y.P., J.L., D.L., Y.P., Y. Wei, Y.C., Q.L., Z.Z., W.D., Z.Y., M.W., N.M., Z.M., Y. Wang, L.L.).,China National Clinical Research Center for Neurological Diseases, Beijing (Y.D., X.N., Y.P., J.L., D.L., H.Y., Y.P., Y. Wei, Y.C., Q.L., Z.Z., W.D., Z.Y., M.W., N.M., Z.M., Y. Wang, L.L.)
| | - Liping Liu
- Department of Neurology (Y.D., X.N., Y.P., J.L., D.L., Y.P., Y. Wei, Y.C., Q.L., Z.Z., W.D., Z.Y., M.W., N.M., Z.M., Y. Wang, L.L.).,China National Clinical Research Center for Neurological Diseases, Beijing (Y.D., X.N., Y.P., J.L., D.L., H.Y., Y.P., Y. Wei, Y.C., Q.L., Z.Z., W.D., Z.Y., M.W., N.M., Z.M., Y. Wang, L.L.)
| | | |
Collapse
|